{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Amyotrophic lateral sclerosis or motor neuron disease",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_riluzole",
          "type": "Drug",
          "label": "Riluzole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_edaravone",
          "type": "Drug",
          "label": "Edaravone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_n_acetylcysteine",
          "type": "Drug",
          "label": "N-acetylcysteine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_gabapentin",
          "type": "Drug",
          "label": "Gabapentin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mestinon",
          "type": "Drug",
          "label": "Mestinon",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lacosamide",
          "type": "Drug",
          "label": "Lacosamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexpramipexole",
          "type": "Drug",
          "label": "Dexpramipexole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tirasemtiv",
          "type": "Drug",
          "label": "Tirasemtiv",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sargramostim",
          "type": "Drug",
          "label": "Sargramostim",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_carnitine",
          "type": "Drug",
          "label": "Carnitine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_risankizumab",
          "type": "Drug",
          "label": "Risankizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ataluren",
          "type": "Drug",
          "label": "Ataluren",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Disease_MND",
          "type": "Disease",
          "label": "Amyotrophic lateral sclerosis or motor neuron disease",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_glutamate_receptor",
          "type": "Target",
          "label": "Glutamate receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_neuroprotective_signaling",
          "type": "Pathway",
          "label": "Neuroprotective signaling pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_motor_neuron_decay",
          "type": "Phenotype",
          "label": "Motor Neuron Decay",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Riluzole",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Edaravone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "N-acetylcysteine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Gabapentin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Mestinon",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Lacosamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Dexpramipexole",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tirasemtiv",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Sargramostim",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Carnitine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Risankizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Ataluren",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_riluzole",
          "target": "target_glutamate_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知靶向谷氨酸受体"
        },
        {
          "source": "drug_edaravone",
          "target": "pathway_neuroprotective_signaling",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "证据表明其参与神经保护通路"
        },
        {
          "source": "drug_n_acetylcysteine",
          "target": "target_glutamate_receptor",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "可降低谷氨酸毒性"
        },
        {
          "source": "drug_gabapentin",
          "target": "pathway_neuroprotective_signaling",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "对神经保护作用的作用有相关路径"
        },
        {
          "source": "drug_mestinon",
          "target": "phenotype_motor_neuron_decay",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可缓解肌肉无力症状"
        },
        {
          "source": "drug_lacosamide",
          "target": "target_glutamate_receptor",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "与谷氨酸受体作用相关"
        },
        {
          "source": "drug_dexpramipexole",
          "target": "pathway_neuroprotective_signaling",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "与神经保护相关的机制"
        },
        {
          "source": "drug_tirasemtiv",
          "target": "phenotype_motor_neuron_decay",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "探索其增强运动神经细胞的能力"
        },
        {
          "source": "drug_sargramostim",
          "target": "pathway_neuroprotective_signaling",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "涉及神经保护领域的研究"
        },
        {
          "source": "drug_carnitine",
          "target": "phenotype_motor_neuron_decay",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "可能缓解神经退行性变化"
        },
        {
          "source": "drug_risankizumab",
          "target": "target_glutamate_receptor",
          "relation": "inhibits",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "对相关靶点有一定抑制作用"
        },
        {
          "source": "drug_ataluren",
          "target": "phenotype_motor_neuron_decay",
          "relation": "supports",
          "weight": 0.25,
          "agent": "Proponent",
          "rationale": "针对某些相关遗传机制的探讨"
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.79,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.1,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "靶向谷氨酸受体的机制明确且已在临床应用中验证"
            ],
            "safety_risk": [
              "无严重安全性问题报道"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.65,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "证据显示其参与神经保护通路，适用于ALS患者"
            ],
            "safety_risk": [
              "安全性数据支持其使用"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.7,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "可降低谷氨酸毒性，支持神经保护"
            ],
            "safety_risk": [
              "安全性尚可接受，需关注长期使用"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.65,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.6,
            "safety_risk": 0.15,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "主要作用于神经保护机制，但证据弱"
            ],
            "safety_risk": [
              "可接受的安全性，然而适应症不明确"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.5,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "适用性不强，主要针对肌肉无力症状"
            ],
            "safety_risk": [
              "风险较低，但需关注个体差异"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.45,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.55,
            "safety_risk": 0.05,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "对谷氨酸受体相关机制较弱支持"
            ],
            "safety_risk": [
              "安全性相对良好"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.5,
            "safety_risk": 0.05,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "支持神经保护的证据较少"
            ],
            "safety_risk": [
              "安全性状况良好"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.53,
          "components": {
            "mechanism_fit": 0.45,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.45,
            "safety_risk": 0.05,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.45,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "机制支持不够充足，其药理尚在实验阶段"
            ],
            "safety_risk": [
              "安全性问题较小"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.35,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.4,
            "safety_risk": 0.05,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "作用机制与ALS的关联性尚不明确"
            ],
            "safety_risk": [
              "安全性尚可接受"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.48,
          "components": {
            "mechanism_fit": 0.35,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.3,
            "indication_plausibility": 0.4,
            "safety_risk": 0.05,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.35,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "作用机制和疗效缺乏实证支持"
            ],
            "safety_risk": [
              "安全性良好，需监测疗效"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.45,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.3,
            "indication_plausibility": 0.35,
            "safety_risk": 0.05,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.3,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "与ALS机制关联性低，缺乏直接证据支持"
            ],
            "safety_risk": [
              "安全性尚可接受"
            ]
          },
          "confidence": "low",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.4,
          "components": {
            "mechanism_fit": 0.25,
            "class_prior": 0.25,
            "pk_pd_feasibility": 0.25,
            "indication_plausibility": 0.3,
            "safety_risk": 0.05,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.25,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "机制上不支持ALS的治疗，证据较弱"
            ],
            "safety_risk": [
              "安全性不错，但缺乏有效疗法的支持"
            ]
          },
          "confidence": "low",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_riluzole",
            "via": [
              "target_glutamate_receptor"
            ],
            "to": "Disease_MND",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "Riluzole的长期使用安全性",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "评估Riluzole对ALS患者的疗效与安全性",
          "讨论谷氨酸受体在ALS干预中的重要性"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_edaravone",
            "via": [
              "pathway_neuroprotective_signaling"
            ],
            "to": "Disease_MND",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "Edaravone的潜在副作用",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "探讨Edaravone在ALS中的应用前景",
          "分析神经保护机制的理论支持"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_n_acetylcysteine",
            "via": [
              "target_glutamate_receptor"
            ],
            "to": "Disease_MND",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "N-acetylcysteine的长期治疗安全性",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "评估N-acetylcysteine在ALS患者中的疗效",
          "关注其安全性与副作用"
        ]
      }
    ],
    "pruned_hypotheses": [
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "seed_request": {
      "should_regenerate": true,
      "reason": "现有假设中缺乏足够的路径独立性与交叉机制，支持路径数量不足且需进一步验证安全性问题。",
      "n": 4
    }
  }
}